Frag 176-191 Nasal 500 mcg

Description

Fragment 176-191, also known as HGH Frag 176-191, is a synthetic peptide sequence that represents a modified portion of the human growth hormone molecule—specifically the amino acids 176 to 191. Unlike full-length HGH, this fragment has been shown in preclinical studies to retain the fat-reducing properties of HGH while minimizing unwanted anabolic or diabetogenic effects.

By targeting specific metabolic pathways, Fragment 176-191 has been studied for its ability to enhance lipolysis (fat breakdown) and inhibit lipogenesis (fat formation), particularly in adipose tissues. It does not raise IGF-1 levels significantly, making it a potential research tool for selective fat loss without affecting muscle growth or blood glucose.

How Fragment 176-191 Works:

• Mimics the lipolytic action of human growth hormone

• Binds to fat cell receptors to stimulate fat breakdown

• Does not significantly affect blood sugar or IGF-1 levels

• Offers targeted action on adipose tissue in animal models

Potential Benefits (Based on Preclinical Research):

• Promotes reduction in body fat, especially abdominal adiposity

• Minimal impact on blood glucose or insulin sensitivity

• Does not stimulate unwanted growth-related pathways

• May support metabolic regulation and weight management

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.